Reassessing carbamazepine in the treatment of bipolar disorder: Clinical implications of new data

David L. Ginsberg, Hagop S. Akiskal, Paul E. Keck, Matthew A. Fuller, Richard H. Weisler, Robert M.A. Hirschfeld, Eric Hollander

Research output: Contribution to journalArticle

12 Scopus citations

Fingerprint Dive into the research topics of 'Reassessing carbamazepine in the treatment of bipolar disorder: Clinical implications of new data'. Together they form a unique fingerprint.

Medicine & Life Sciences